Guangzhou Baiyunshan Pharmaceutical Holdings' (SHA:600332, HKG:0874) net profit attributable to the shareholders in the first half slipped 1.3% year on year to 2.52 billion yuan, or 1.548 yuan per share, according to a Hong Kong disclosure on Saturday.

The Chinese pharmaceutical company's Hong Kong shares jumped over 4%, and Shanghai shares rose less than 3%.

The attributable profit a year earlier was 2.55 billion yuan, or 1.568 yuan per share.

The operating revenue rose 1.9% to 41.8 billion yuan from 41 billion yuan in the previous year.